HER2 Support Group Forums - View Single Post

Joe · 08-30-2006, 08:32 PM

Genentech has sponsored a trial called RegistHer which is a long term study of bc patients who are HER2+ . Unfortunately the results won't be published until 2009.

The concensus of opinion is that overall, women who are HER2 + have longer survival rates.

Regards
Joe

08-30-2006, 08:32 PM	#7
Joe Webmaster Join Date: Feb 2005 Location: Home of the "Flying Tomato" Carlsbad, CA Posts: 2,036	Genentech has sponsored a trial called RegistHer which is a long term study of bc patients who are HER2+ . Unfortunately the results won't be published until 2009. The concensus of opinion is that overall, women who are HER2 + have longer survival rates. Regards Joe __________________ A Proud webmaster to the internet's most informed, educated, COMPASSIONATE and caring group of breast cancer survivors. Illegitimi non carborundum My Album